HAP1 and cancer: To identify Food and Drug Administration (FDA)-approved drugs that selectively target cancer cells with inactivated RNF43 and PWWP2B genes, we performed a high-throughput screening of 1,449 drugs in HAP1, HAP1 RNF43 KO, and HAP1 PWWP2B KO cells.